cm 40907 has been researched along with Epilepsy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duncan, JS; Shorvon, SD; Yepez-Lasso, R | 1 |
| Biziere, K; Brochard, J; Brodin, R; Chambon, JP; Hallot, A; Heaulme, M; Roncucci, R | 1 |
1 trial(s) available for cm 40907 and Epilepsy
| Article | Year |
|---|---|
Suppression of inter-ictal spikes by CM40907. A double-blind placebo-controlled investigation and review of spike counting as a methodology for assessing the antiepileptic effect of drugs.
Topics: Adolescent; Adult; Anticonvulsants; Double-Blind Method; Electroencephalography; Epilepsy; Female; Humans; Male; Middle Aged; Placebos; Pyridazines | 1990 |
1 other study(ies) available for cm 40907 and Epilepsy
| Article | Year |
|---|---|
CM 40907: a structurally novel anticonvulsant in mice, rats and baboons.
Topics: Animals; Anticonvulsants; Behavior, Animal; Brain Chemistry; Electroshock; Epilepsy; Female; Flunitrazepam; gamma-Aminobutyric Acid; In Vitro Techniques; Kindling, Neurologic; Male; Mice; Mice, Inbred Strains; Papio; Pyridazines; Rats; Rats, Inbred Strains; Receptors, GABA-A; Tritium | 1985 |